Prime Minister's Prizes for Science nominations open
18 February, 2011 by Staff WritersNominations are now open for the prestigious Prime Minister's Prizes for Science.
Managing acquisition - how to get it right
17 February, 2011 by Matthew SainsburyAcquisitions are commonplace in the IT industry. ARN investigates what makes the difference between a successful acquisition or merger, and where things can (and do) go wrong.
bioMD makes a bid for Andrew Forest's Allied Medical and Coridon
15 February, 2011 by Staff WritersbioMD is looking to acquire Allied Medical, which also owns Coridon, led by Ian Frazer, to produce a new diversified healthcare company.
Feature: To be a lab manager
11 February, 2011 by David BinningKeeping a life science lab running smoothly and safely has become an increasingly complex and demanding task.
Danaher to acquire Beckman Coulter for US$6.8 billion
09 February, 2011 by Staff WritersUS technology company, Danaher, is to acquire Beckman Coulter in a deal worth US$6.8 billion.
Feature: Free radical
02 February, 2011 by Fiona WylieDr Uta Wille bridges the gap between chemistry and biology and is bringing her unique insight to bear on the role played by free radicals in damaging DNA.
Report card highlights Australia's research strengths and weaknesses
31 January, 2011 by Tim DeanThe Excellence in Research for Australia 2010 report shows that Australian researchers produce world class output in immunology, quantum physics and history, but fall behind in other areas.
Government report reveals best universities in life science research
31 January, 2011 by Tim DeanEight out of the 34 universities surveyed in the Excellence in Research Australia report produce life science research that is well above the world standard.
AAS to hold Frank Fenner tribute public symposium
28 January, 2011 by Staff WritersThe Australian Academy of Science will hold a public lecture series that will serve as a tribute to the life and achievements of the late Frank Fenner.
Mike Hirshorn joins LBT Innovations board
24 January, 2011 by Staff WritersBiotechnology industry veteran, Mike Hirshorn, appointed as non-executive director of clinical and diagnostic technology company LBT Innovations (ASX:LBT).
Floods shut down University of Queensland
13 January, 2011 by Tim DeanThe University of Queensland campus at St Lucia has been hit by the once in a century flood.
LCT expands NZ trial of Diabecell to gather crucial dose-related data
20 December, 2010 by David BinningAustralian xenotransplantation pioneers Living Cell Technologies announced today that the New Zealand minister of health has approved the expansion of the company’s clinical trial of Diabecell, a porcine-based implant designed to treat Type 1 diabetes.
Market report: Biotechs up for sixth week in a row
17 December, 2010 by David BinningS&P/ASX 200 Heathcare Index closed just 22 points shy of 9000 today after notching up its sixth consecutive week in the black.
Mayne applies to register Subacap in Europe
17 December, 2010 by Staff WritersMayne Pharma Group has applied for a marketing authorisation application (MAA) with the European Union (EU) for the sale and supply of its Subacap drug to treat fungal infections.
Thermo Fisher to acquire Dionex for $2.1 billion
14 December, 2010 by Staff WritersThermo Fisher continues its acquisition frenzy by agreeing to buy laboratory equipment manufacturer, Dionex, for US$2.1 billion ($2.11 billion).
